• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2.5%琼脂糖凝胶与透明质酸填充剂治疗中重度鼻唇沟皱纹的比较。

Comparison of 2.5% agarose gel vs hyaluronic acid filler, for the correction of moderate to severe nasolabial folds.

机构信息

Department of General and Plastic Surgery, University of La Sapienza, Rome, Italy, Italy.

Plastic Surgery Unit, Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy.

出版信息

J Cosmet Dermatol. 2021 May;20(5):1512-1519. doi: 10.1111/jocd.13962. Epub 2021 Feb 7.

DOI:10.1111/jocd.13962
PMID:33533155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8248355/
Abstract

BACKGROUND

Agarose gel filler is a natural hydrocolloid with a three-dimensional structure similar to the extracellular matrix, with gel formed by hydrogen bonds and electrostatic interactions rather than through chemical cross-linking or polymerization.

OBJECTIVE

To determine efficacy and safety of 2.5% agarose gel filler for the correction of nasolabial folds.

METHODS

In this split-face study, efficacy, safety, and usability of 2.5% agarose gel were compared to those of NASHA-L. Assessments included the nasolabial fold (NLF) Wrinkle Severity Rating Scale (WSRS), Global Aesthetic Improvement Scale (GAIS [blinded investigator]), subject satisfaction, safety (adverse events), and usability.

RESULTS

Sixty-six subjects were treated, and 46/66 (66.7%) were available for evaluation at 3 months, when mean change in WSRS was identical for both products (-1.1 ± 0.4 for 2.5% agarose; -1.1 ± 0.4 for NASHA-L). Scores for each product remained similar across all time points and began to return to baseline between 7 and 8 months. GAIS score followed a similar pattern, rising between months 7 and 8 (2.7 ± 0.6 for 2.5% agarose at month 7-3.3 ± 0.5 at month 8 and 2.7 ± 0.6 for NASHA-L at month 7-3.3 ± 0.5 at month 8). Ultrasound confirmed the longevity of both fillers between 7 and 8 months. All adverse events were transient in nature and resolved within 15 days. Most events were mild in nature, and the number of events was similar between the two fillers.

CONCLUSION

Treatment with 2.5% agarose gel resulted in improvement that persisted for between 7 and 8 months. The treatment effect was equivalent to NASHA-L.

摘要

背景

琼脂糖凝胶填充剂是一种天然水凝胶,具有与细胞外基质相似的三维结构,通过氢键和静电相互作用形成凝胶,而不是通过化学交联或聚合。

目的

评估 2.5%琼脂糖凝胶填充剂矫正鼻唇沟的疗效和安全性。

方法

在这项分面研究中,比较了 2.5%琼脂糖凝胶与 NASHA-L 的疗效、安全性和可用性。评估包括鼻唇沟皱纹严重程度评分量表(WSRS)、总体美学改善量表(GAIS[盲法评估者])、患者满意度、安全性(不良反应)和可用性。

结果

66 例患者接受了治疗,46/66(66.7%)例患者在 3 个月时可进行评估,两种产品的 WSRS 平均变化值相同(2.5%琼脂糖组为-1.1±0.4;NASHA-L 组为-1.1±0.4)。在所有时间点,两种产品的评分均相似,并且在 7 至 8 个月之间开始恢复基线。GAIS 评分也呈现类似的模式,在 7 至 8 个月之间升高(2.5%琼脂糖组:7 个月时为 2.7±0.6,3 个月时为 3.3±0.5;NASHA-L 组:7 个月时为 2.7±0.6,3 个月时为 3.3±0.5)。超声确认两种填充物在 7 至 8 个月之间的持久性。所有不良反应均为一过性,在 15 天内消退。大多数事件为轻度,两种填充物的事件数量相似。

结论

2.5%琼脂糖凝胶治疗可使鼻唇沟改善持续 7 至 8 个月。治疗效果与 NASHA-L 相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/436d76130cb3/JOCD-20-1512-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/a712d0af0a99/JOCD-20-1512-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/065c03d56a53/JOCD-20-1512-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/18b80809cc10/JOCD-20-1512-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/b4ffba400866/JOCD-20-1512-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/615654ccc60e/JOCD-20-1512-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/436d76130cb3/JOCD-20-1512-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/a712d0af0a99/JOCD-20-1512-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/065c03d56a53/JOCD-20-1512-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/18b80809cc10/JOCD-20-1512-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/b4ffba400866/JOCD-20-1512-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/615654ccc60e/JOCD-20-1512-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a303/8248355/436d76130cb3/JOCD-20-1512-g005.jpg

相似文献

1
Comparison of 2.5% agarose gel vs hyaluronic acid filler, for the correction of moderate to severe nasolabial folds.2.5%琼脂糖凝胶与透明质酸填充剂治疗中重度鼻唇沟皱纹的比较。
J Cosmet Dermatol. 2021 May;20(5):1512-1519. doi: 10.1111/jocd.13962. Epub 2021 Feb 7.
2
Efficacy and safety of two hyaluronic acid fillers with different injection depths for the correction of moderate-to-severe nasolabial folds: A 52-week, prospective, randomized, double-blinded study in a Chinese population.两种不同注射层次透明质酸填充剂矫正中重度鼻唇沟的疗效和安全性:一项在中国人群中进行的为期 52 周、前瞻性、随机、双盲研究。
J Cosmet Dermatol. 2022 Mar;21(3):940-948. doi: 10.1111/jocd.14744. Epub 2022 Jan 12.
3
A multi-center comparative efficacy and safety study of two different hyaluronic acid fillers for treatment of nasolabial folds in a Chinese population.一项多中心、比较两种不同透明质酸填充剂治疗中国人群鼻唇沟皱纹的疗效和安全性的研究。
J Cosmet Dermatol. 2019 Jun;18(3):755-761. doi: 10.1111/jocd.12916. Epub 2019 May 10.
4
The Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds: A Multicenter, Randomized Clinical Study.含利多卡因的透明质酸真皮填充剂治疗鼻唇沟的疗效和安全性:一项多中心随机临床研究
Aesthetic Plast Surg. 2015 Dec;39(6):953-62. doi: 10.1007/s00266-015-0571-z. Epub 2015 Oct 22.
5
Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.两种高弹性透明质酸填充剂治疗中重度鼻唇沟皱纹的疗效和安全性:一项 64 周、前瞻性、多中心、对照、随机、双盲、自身对照研究。
Dermatol Surg. 2020 Dec;46(12):1521-1529. doi: 10.1097/DSS.0000000000002391.
6
A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds.一项比较聚己内酯与透明质酸治疗鼻唇沟的随机、前瞻性、双盲、半脸、单中心研究。
J Cosmet Dermatol. 2015 Mar;14(1):27-32. doi: 10.1111/jocd.12126. Epub 2015 Jan 6.
7
A Single-Center, Randomized, Double-Blind Clinical Trial to Compare the Efficacy and Safety of a New Monophasic Hyaluronic Acid Filler and Biphasic Filler in Correcting Nasolabial Fold.一项单中心、随机、双盲临床试验,旨在比较新型单相透明质酸填充剂和双相填充剂在纠正鼻唇沟中的疗效和安全性。
Aesthetic Plast Surg. 2021 Dec;45(6):2902-2908. doi: 10.1007/s00266-021-02252-0. Epub 2021 Apr 13.
8
Reduced pain with injection of hyaluronic acid with pre-incorporated lidocaine for nasolabial fold correction: A multicenter, double-blind, randomized, active-controlled, split-face designed, clinical study.预先掺入利多卡因的透明质酸注射用于鼻唇沟矫正时疼痛减轻:一项多中心、双盲、随机、活性对照、半脸设计的临床研究。
J Cosmet Dermatol. 2020 Dec;19(12):3229-3233. doi: 10.1111/jocd.13421. Epub 2020 May 16.
9
Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds in Chinese subjects: BioHyalux versus Restylane.两种透明质酸填充剂治疗中国受试者鼻唇沟的临床比较:润致美与瑞蓝。
Arch Dermatol Res. 2016 Apr;308(3):145-51. doi: 10.1007/s00403-016-1630-2. Epub 2016 Feb 29.
10
Monophasic versus biphasic hyaluronic acid filler for correcting nasolabial folds: a systematic review and meta-analysis.单相与双相对比用于纠正鼻唇沟的透明质酸填充剂:系统评价和荟萃分析。
J Cosmet Dermatol. 2022 Feb;21(2):627-635. doi: 10.1111/jocd.14632. Epub 2021 Nov 24.

引用本文的文献

1
The Effects of Subcutaneously Injected Novel Biphasic Cross-Linked Hyaluronic Acid Filler: An In Vivo Study.皮下注射新型双相交联透明质酸填充剂的效果:一项体内研究。
Aesthetic Plast Surg. 2022 Apr;46(Suppl 1):174-175. doi: 10.1007/s00266-021-02200-y. Epub 2021 Mar 10.

本文引用的文献

1
The use of algeness in the face and neck: a safe, alternative filler for cosmetics and reconstruction.藻酸盐在面部和颈部的应用:一种用于美容和重建的安全替代填充剂。
Ann Transl Med. 2020 Mar;8(6):362. doi: 10.21037/atm.2020.02.52.
2
Agarose-based biomaterials for tissue engineering.基于琼脂糖的组织工程生物材料。
Carbohydr Polym. 2018 May 1;187:66-84. doi: 10.1016/j.carbpol.2018.01.060. Epub 2018 Jan 31.
3
New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events.用于透明质酸填充剂血管不良事件的新型高剂量脉冲透明质酸酶方案
Aesthet Surg J. 2017 Jul 1;37(7):814-825. doi: 10.1093/asj/sjw251.
4
Hyaluronidase: from clinical applications to molecular and cellular mechanisms.透明质酸酶:从临床应用到分子与细胞机制
Eur J Med Res. 2016 Feb 13;21:5. doi: 10.1186/s40001-016-0201-5.
5
Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.美容用皮肤填充剂:不良事件及处理方法概述。
Clin Cosmet Investig Dermatol. 2013 Dec 12;6:295-316. doi: 10.2147/CCID.S50546.
6
A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers.1,4-丁二醇二缩水甘油醚交联透明质酸真皮填充剂代谢的综述。
Dermatol Surg. 2013 Dec;39(12):1758-66. doi: 10.1111/dsu.12301. Epub 2013 Aug 13.
7
Agarose gel electrophoresis for the separation of DNA fragments.用于分离DNA片段的琼脂糖凝胶电泳。
J Vis Exp. 2012 Apr 20(62):3923. doi: 10.3791/3923.
8
Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications.可注射和可生物降解水凝胶:凝胶化、生物降解和生物医学应用。
Chem Soc Rev. 2012 Mar 21;41(6):2193-221. doi: 10.1039/c1cs15203c. Epub 2011 Nov 24.
9
Lip augmentation with a new filler (agarose gel): a 3-year follow-up study.使用新型填充剂(琼脂糖凝胶)进行唇部填充:一项为期3年的随访研究。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Aug;108(2):e11-5. doi: 10.1016/j.tripleo.2009.04.025.
10
Biocompatibility of agarose gel as a dermal filler: histologic evaluation of subcutaneous implants.
Plast Reconstr Surg. 2007 Oct;120(5):1161-1169. doi: 10.1097/01.prs.0000279475.99934.71.